Body composition alteration and inflammation are independent predictors of survival in lung cancer patients treated with anlotinib
2019 ◽
Vol Volume 11
◽
pp. 8201-8207
◽
Keyword(s):
Keyword(s):
Keyword(s):
2002 ◽
Vol 29
(6 Suppl 19)
◽
pp. 38-41
◽
Keyword(s):
Keyword(s):